Association of a Lung Screening Program Coordinator With Adherence to Annual CT Lung Screening at a Large Academic Institution

Determinants Associated With Longitudinal Adherence to Annual Lung Cancer Screening: A Retrospective Analysis of Claims Data

“…Our 18-month adherence rate was 46%; this is consistent with the 37% to 66% reported LCS adherence outside of clinical trials [22][23][24][25][26][27]. This may be related to our CO APCD sample being biased by clinicians or programs that are early LCS adopters as overall LCS uptake remains low, with only 2% to 16% of eligible individuals currently receiving LCS [46][47][48][49][50].…”

“…Early descriptions of LCS adherence determinants [31,32] came from clinical trials performed before clear proof that LCS reduced mortality and are difficult to contextualize in an environment in which LCS is a preventive service delivered in community settings and is now covered by most insurance plans. More recent studies in academic [23][24][25][26][27], community [22], or federal health [33] settings have emerged, but no prior studies have used insurance claims to assess LCS adherence [20,21]. Using longitudinal claims data, we found that ages 55 to 64 and 75 to 79, rural residence, and Medicare FFS and Medicaid insurance are associated with reduced adherence to annual LCS.…”

“…Determinants of cancer screening adherence are multifaceted and include both individual factors (demographics, income, beliefs) and health care system factors (insurance, accessibility, clinician recommendation) [10][11][12][13][14][15][16][17][18][19][20][21]. Early reports of real-world screening cohorts describe LCS annual adherence rates outside clinical trials between 37% and 66% [22][23][24][25][26][27]. Recent systemic reviews and metaanalyses found higher adherence in participants in their 60s and former (as opposed to current) smokers and lower adherence in racial minorities, individuals with less education, and individuals who lived further from the screening facility [20,21].…”

Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement

“…Program coordinators, different from patient navigators, who are responsible for day-to-day administrative and operational LCS tasks can be integral in the success of LCS programs ( 116 ). This may occur through the implementation of electronic population-health-management tools and LCS tracking software to identify eligible patients, track and report LDCT results, coordinate clinical care, and communicate with patients.…”

“…This may occur through the implementation of electronic population-health-management tools and LCS tracking software to identify eligible patients, track and report LDCT results, coordinate clinical care, and communicate with patients. Indeed, LCS coordinators may increase screening adherence, particularly in vulnerable populations, after a negative baseline LDCT examination ( 116 ).…”